Shemesh, Avishai; Carter, Shenrae; Hays, Steven R; Singer, Jonathan P; Greenland, John R; Calabrese, Daniel R
doi: 10.1093/ajrcmb/aanag017pmid: 41738213
Lung transplantation prolongs survival for many patients with end-stage lung diseases, though long-term outcomes are limited due to allograft inflammation leading to chronic rejection. In this study, we aimed to identify the role of natural killer (NK) cell receptors in lung transplant recipient outcomes. We hypothesized that cystic fibrosis (CF) may be a model for systemic inflammation. Peripheral blood mononuclear cells were collected from recipients with CF (n = 6), recipients with chronic obstructive pulmonary disease (n = 6), and healthy donors (n = 7) for NK cell immunophenotyping via spectral flow cytometry and functional killing assays. Plasma B7H6 was also measured in 2 independent lung transplant cohorts to test the association with rejection. We identified a CF-specific reduction in NKp30 receptor expression, validated functionally against cells expressing the B7H6 ligand. The NKp30 reduction was not NK cell subset specific, suggesting a systemic influence. Further, we found that B7H6 in vitro reduced NKp30-mediated killing of target cells in a dose-dependent fashion. Analysis of soluble B7H6 concentrations in plasma revealed higher soluble B7H6 in CF recipients relative to other groups, suggesting a potentially broader role of soluble B7H6 in lung transplant outcomes. Consequently, B7H6 was higher in recipients without acute graft dysfunction, and higher B7H6 plasma concentrations conferred reduced risk of chronic lung allograft dysfunction (CLAD) and mortality. Single-cell RNA sequencing showed that B7H6 transcripts were most prevalent on ciliated airway epithelial cells and bronchoalveolar lavage monocytes and that airway B7H6 transcripts were reduced in CLAD. Thus, our data reveal a new role of the NKp30–B7H6 axis in potentiating lung allograft outcomes.
Wang, Yongxing; Kulkarni, Vikram V; Pantaleón García, Jezreel; Ntita, Mbaya; Chavez, Miguel A; Reese, Tanner C; Liu, Yun; Vila Ellis, Lisandra; Tuvim, Michael J; Evans, Scott E
Yamamoto, Shota; Wilson, Carole L; Krueger, Melissa A; Gharib, Sina A; Schnapp, Lynn M
doi: 10.1093/ajrcmb/aanag009pmid: 41738268
Mannose receptor C type 2 (MRC2) is highly expressed in the lung and is the major endocytic receptor for the internalization and degradation of collagen in mesenchymal cells. Using Mrc2 knockout (KO) mice, we previously showed that MRC2 is required for efficient clearance of collagen in bleomycin-induced fibrosis. However, MRC2 also interacts with various cell-surface receptors and ligands beyond collagens, indicating that MRC2 may have additional, previously unrecognized functions in fibroblasts. To uncover novel pathways regulated by MRC2, we took an unbiased approach to compare the transcriptomic profile of MRC2-deficient lung fibroblasts to WT after in vitro culture. RNA-seq analysis revealed upregulation of the expression of several extracellular matrix genes but unexpectedly showed changes in expression of several cell cycle genes, including that encoding Forkhead box M1 (FOXM1), a key regulator of cell cycle progression, and enrichment of pathways involved in mitosis and cell division. Both in vitro and in vivo functional assays demonstrated that a greater proportion of MRC2-deficient lung stromal cells progress through the cell cycle more rapidly than WT cells, thereby accelerating overall proliferation. Inhibitor experiments showed that actively proliferating Mrc2 KO fibroblasts are more reliant on FOXM1 activity compared with WT cells, suggesting that FOXM1 is a critical mediator in fibroblast proliferation in the absence of MRC2. Our findings point to an unexpected role for this endocytic receptor in the regulation of lung stromal cell proliferation.
Jiménez-Garcia, Lidia; Pérez-Montero, Andrea; Herranz, Sandra; Luque, Alfonso; Tarín, Carlos; Castillo, Diego; Lopez-Vilaro, Laura; Mariñas-Pardo, Luis; McCarthy, Cormac; Acebo, Paloma; Hortelano, Sonsoles
Showing 1 to 10 of 10 Articles
The vacuolar H+-ATPase (V-ATPase) is an enzymatic complex responsible for pumping H+ into the cytosol, thereby maintaining intracellular pH; however, its role in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is unclear. In this study, the functional relevance of V-ATPase and hypoxia inducible factor (HIF) 1 were assessed using alveolar-specific ATP6V0C knockout mice (Atp6v0cAT2-KO) and HIF1A knockout mice (Hif1aAT2-KO), respectively. ATP6V0C expression levels were measured in serum and bronchoalveolar lavage fluid (BALF) of patients with ARDS. ATP6V0C expression was increased in lung tissues from ALI murine models and BALF from patients with severe ARDS. Genetic deficiency of ATP6V0C in alveoli attenuated the functional, histologic, and inflammatory hallmarks of lipopolysaccharide (LPS)–induced ALI but did not alter the host’s susceptibility to bacterial pathogens. Mechanistically, transcriptomic analyses revealed that ATP6V0C-regulated genes are highly enriched in the HIF-1 signaling pathway. HIF-1α was upregulated synchronously with ATP6V0C in injured lungs, while co-immunoprecipitation confirmed their interaction. Following LPS instillation, the signs of ALI were further exacerbated in Hif1afl/fl mice pretreated with lung epithelial tropic adeno-associated virus carrying ATP6V0C, but not in Hif1aAT2-KO mice. HIF-1α, as a transcriptional factor, in turn, regulated ATP6V0C expression, forming a positive feedback loop. ATP6V0C levels were increased in BALF but not serum in patients with ARDS. ATP6V0C levels in BALF correlate with ARDS severity. In summary, our study identified an ATP6V0C–HIF-1α detrimental feedback loop that exacerbates epithelial apoptosis and inflammation, thereby driving the progression of ALI. Targeting the ATP6V0C–HIF-1α loop may hence present a promising therapeutic strategy against ALI/ARDS.
Pneumonias remain a leading cause of death worldwide. Seeking novel strategies to protect susceptible patients, we have reported that inhaled delivery of a diacylated lipopeptide and a synthetic CpG oligodeoxynucleotide (ODN) protects animals against a broad range of infectious pneumonias by stimulating antimicrobial responses from the lung epithelium. Toll-like receptor 9 (TLR9) is well-established as the primary cellular receptor for CpG ODNs. However, we recently reported that ODNs also stimulate TLR9-independent generation of antimicrobial mitochondrial reactive oxygen species. By testing a variety of synthetic ODN molecules, we found that ODNs containing a phosphorothioate backbone, but not those with a phosphodiester backbone, induce TLR9-independent pathogen killing in lungs and improve mouse survival. Phosphorothioate-backboned ODN binds mitochondrial protein voltage-dependent anion channel 1 (VDAC1) at its N-terminus, initiating pneumonia-protective metabolic reprogramming in lung epithelial cells that yield the protective antimicrobial effect. Thus, the phosphorothioate backbone of ODN is a critical structural pattern that activates TLR9-independent, metabolically modulated innate immune protection that may be harnessed to protect vulnerable patients against pneumonia.
RationaleMechanical ventilation is integral to the medical management of the critically ill. However, prolonged exposure to pathologic airflow during mechanical ventilation places patients at risk for airway injury. Here, we developed an innovative microsurgical mouse model to examine how changes in airflow affect cellular regeneration and repair in the tracheobronchial airway. We examined wall shear stress (WSS), a known consequence of airflow constriction, and evaluated clinical significance using Heliox, a helium-rich environment, which reduces pathologic airflow in human patients.MethodsWe modulated airflow by altering airway geometry. Specifically, orthotopic airway transplants replaced a tracheal segment with either a bronchial scaffold or a tracheal scaffold (control) (n = 10/group). After surgery, mice were subjected to room air (1 or 2 weeks) or Heliox (1 week). Computational fluid dynamics models were used to quantify WSS. Epithelial and fibroblast cell number and phenotype, as well as collagen density, were analyzed using histology. Statistical analysis was performed using 1-way analysis of variance with a multiple comparison test.ResultsUsing our novel microsurgical model, we reduced airway cross-sectional area by 0.54-fold and increased WSS by 71.40-fold. This increase in WSS was associated with squamous epithelial differentiation, increased fibroblast activation, and significant fibrosis. These phenotypic changes were rescued when mice were recovered in Heliox.ConclusionsOur findings suggest a mechanical mechanism in which airflow regulates epithelial differentiation, fibroblast activation, and fibrosis in the tracheobronchial airway. These studies support the development of therapeutic interventions that modulate intraluminal WSS and have the potential to accelerate airway regeneration.
The alternative reading frame (ARF) protein, encoded by the CDKN2A locus, is well-recognized for its role in tumor suppression. Emerging evidence has highlighted ARF as a critical regulator of innate immunity and inflammation, with links to increased susceptibility to cardiometabolic diseases. This study investigates the role of ARF in lung homeostasis and reveals that its deficiency in mice affects lipid metabolism and leads to pulmonary abnormalities resembling pulmonary alveolar proteinosis (PAP). ARF-deficient mice exhibited abnormal surfactant clearance, characterized by lipid and protein accumulation in the alveoli, foamy alveolar macrophages (AMs) with enlarged and vacuolated morphology, and increased bronchoalveolar lavage fluid turbidity. These changes were linked to disrupted surfactant homeostasis resulting from an imbalance between increased lipid uptake (via upregulation of scavenger receptors such as SR-A1 and CD36) and impaired lipid efflux, evidenced by reduced expression of the cholesterol transporter SR-BI. These mice also display reduced AM numbers, increased eosinophil and neutrophil infiltration, consistent with secondary PAP. Additionally, a distinctive chemokine and cytokine profile (elevated Ccl12, Ccl2, Cxcl1, and IL-10) was observed, which may be associated with type 2 immune responses and alternative AM polarization. Interestingly, ARF deficiency also appears to compromise AM maintenance through effects on self-renewal and survival. Pulmonary function tests revealed increased tissue elastance and damping, suggesting early-stage lung stiffness. Collectively, these findings highlight the essential role of ARF in lung homeostasis and lipid regulation, providing insights into its potential involvement in PAP pathogenesis.